Form 4: Clene Director Vallerie McLaughlin Granted Stock Options
Insider Transaction Report
Clene Inc. Director Vallerie McLaughlin was granted 2,083 stock options at an exercise price of $7.30 per share, vesting immediately.
Summary
- Vallerie McLaughlin, a Director of Clene Inc. (CLNN), was granted stock options on November 13, 2025.
- The options are for 2,083 shares of Common Stock, with an exercise price of $7.30 per share.
- These options vest immediately upon grant and were issued under the Clene Inc. Amended 2020 Stock Plan.
- The options are set to expire on November 12, 2035.
- Following this transaction, McLaughlin beneficially owns 2,083 derivative securities (stock options).
Sentiment
Score: 6
Explanation: The grant of stock options to a director is a standard compensation practice that aligns the director's financial interests with the long-term performance of the company, which is generally viewed favorably, though it is a routine disclosure.
Positives
- The grant of stock options to Director Vallerie McLaughlin aligns her financial interests with those of Clene Inc.'s shareholders.
- The immediate vesting of the 2,083 options provides an immediate incentive and strengthens the director's stake in the company's performance.
Negatives
- The potential exercise of these stock options could lead to minor dilution for existing shareholders.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- The grant of stock options to Vallerie McLaughlin, a Director of Clene Inc., constitutes a related party transaction as it involves compensation to a member of the company's board of directors.
Stakeholder Impact
- Shareholders: Potential for minor dilution if options are exercised, but also improved alignment of the director's interests with shareholder value.
- Directors: Vallerie McLaughlin receives equity compensation, aligning her financial incentives with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 11/13/2025 | Date of earliest transaction and option grant date for 2,083 shares. |
| 11/14/2025 | Signature date of the reporting person's power of attorney. |
| 11/12/2035 | Expiration date of the granted stock options. |
Keywords
Clene Inc., CLNN, Form 4, Insider Transaction, Stock Option, Director Compensation, Equity Grant, Vallerie McLaughlin, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.